Table 2.
Mean (SD) | |
---|---|
CHARACTERISTICS | |
#Years worked with PLWH | 11.4 ± 7.7 |
#Years worked at ASO (n = 28) | 8.5 ± 7.1 |
#Clients served, total (n = 25) | 89.0 ± 85.2 |
n (%) | |
SEXUAL ORIENTATION, SEX | |
Heterosexual, female | 12 (40) |
Heterosexual, male | 6 (20) |
Lesbian or gay | 12 (40) |
Employed full time at ASO | 23 (76) |
Worked with HIV-positive women (or HIV-negative women engaging in HIV risk behaviors)a | 28 (93) |
Worked with MSM (HIV-positive and HIV-negative) | 29 (97) |
Worked with clients ≤ 26 years old | 23 (100)b |
Clients have talked to them about the HPV vaccine | 7 (30)b |
Worked with clients who had initiated the 3-dose HPV vaccine series | 7 (30)b |
Worked with clients who had completed the 3-dose HPV vaccine series | 4 (17)b |
Worked with clients who had been diagnosed with an HPV-related disease or cancer | 18 (60) |
AWARENESS | |
Heard of Cervarix® | 12 (52)b |
… Gardasil® | 8 (35)b |
… Gardasil-9® | 18 (78)b |
Heard of the HPV test | 24 (80) |
Heard of an anal Pap test | 19 (66) |
KNOWLEDGE | |
HPV causes more health problems for PLWH | 24 (80) |
Main purpose of the HPV vaccine is to prevent HPV infection | 19 (83)b |
Three doses of the HPV vaccine are recommendedc | 9 (39)b |
HPV vaccine is recommended for females and males ≤ 26 years old | 19 (83)b |
HPV vaccine is recommended for PLWH 9-26 years old | 16 (70)b |
HPV vaccine is not recommended for people >26 years old | 6 (26)b |
Females who have gotten the HPV vaccine still need to get screened for cervical cancer | 21 (91)b |
HPV vaccine is safe | 12 (52)b |
HPV vaccine is effective | 10 (43)b |
BELIEFS | |
Pap test can detect cervical cancer in its earliest stages | 26 (87) |
There's not much a woman can do to lower her chances of getting anal cancer | 1 (3) |
… cervical cancer | 1 (3) |
… oral cancer | 2 (7) |
… vaginal cancer | 13 (43) |
… vulvar cancer | 1 (3) |
There's not much a man can do to lower his chances of getting anal cancer | 1 (3) |
… oral cancer | 1 (3) |
… penile cancer | 13 (45) |
HEALTH CARE ACCESS BARRIERS | |
PATIENT-LEVEL | |
Childcare | 8 (27) |
INTERPERSONAL | |
HPV stigma | 19 (63) |
HIV stigma | 8 (27) |
SYSTEM-LEVEL | |
Clinic hours | 23 (77) |
Cost | 18 (60) |
Health insurance | 15 (50) |
Transportation | 15 (50) |
Travel distance | 14 (47) |
Other | 10 (33) |
ASO, community-based HIV/AIDS service organization; HIV, human immunodeficiency virus; HPV, human papillomavirus; SD, standard deviation.
For example, diagnosed with a sexually transmitted disease within the past year.
n = 23 / 30 who had heard of the HPV vaccine.
3-dose HPV vaccine series was the only recommendation at this time (and is the current recommended for people living with HIV (18).